Capstan Medical
Capstan Medical raises $110M Series C at $600M valuation
Quick Facts
Capstan Medical: Series C Funding Round
Capstan Medical has successfully raised $110M in Series C funding, reaching a valuation of $600M.
Company Overview
Robotic minimally invasive heart valve technology
Funding Details
The Series C round was led by Eclipse Ventures, with participation from Cormorant Asset Management.
Company Information
- Headquarters: Campbell, CA
- Founded: 2018
- Employees: 90+
- Category: MedTech
Investment
Capstan Medical plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Eclipse Ventures: Verified investor in Series C
- Cormorant Asset Management: Verified investor in Series C
Key Investors
About the Author
Related Company Reports
Galvenize Therapeutics Raises $100M Series C to Transform MedTech
Galvenize Therapeutics has secured $100M Series C in funding to accelerate growth and innovation in the medtech sector. Medical device company developing pulsed electric field therapies for cardiac ablation and tumor treatment...
Reprieve Cardiovascular Raises $61M Series B to Transform MedTech
Reprieve Cardiovascular has secured $61M Series B in funding to accelerate growth and innovation in the medtech sector. Cardiovascular device company developing personalized heart failure therapies and monitoring solutions...
ViCentra Raises $85M Series D to Transform MedTech
ViCentra has secured $85M Series D in funding to accelerate growth and innovation in the medtech sector. Medical device company developing innovative insulin patch pumps for diabetes management...
